Like 90Ten

closed 4/9/2020 via BNC Analysis

Envision Pharma Group, acquired 90Ten

synopsis: Global healthcare communications consultancy 90TEN has been acquired by Envision Pharma Group, a global provider of evidence-based communication services and industry-leading technology solutions. The acquisition of 90TEN extends Envision’s footprint in patient engagement and medical communications with its behavioral science methodology.
buyer parent: Ardian
buyer: Envision Pharma Group
Envision Pharma Group is a global technology and scientific communications company serving pharmaceutical, biotechnology, and medical device companies. Envision is a leading provider of evidence-based communication services and industry-leading technology solutions through its iEnvision platform. "
target: 90Ten
90TEN is a global healthcare communications consultancy that aims to make people healthier and happier through education and communications. The company provides PR, medical communications, and patient advocacy services that use behavioral science methodologies to maximize brand and health outcomes.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/27/2022 via PR Newswire

Deerfield Agency of Brand, acquired Verge Scientific Communications, LLC

synopsis: Deerfield Agency, one of the fastest growing independent marketing and commercialization partners for life sciences companies, has acquired Verge Scientific Communications, a Virginia-based, brand strategy and strategic communications agency dedicated to shaping the stories of emerging and pioneering health and science-driven companies.
buyer: Deerfield Agency of Brand
Deerfield is a full-service agency that specializes in healthcare marketing and is founded on the principle of providing extraordinary work at an exceptional value. Deerfield keeps brands at the forefront with its compelling strategy, creative, media, print, and digital innovation. "
target: Verge Scientific Communications, LLC
Verge is a strategic communications firm shaping the stories of pioneering companies and brands. Verge partners with innovator companies pushing the bounds of science, inventing new products, and advancing technologies that change the way people live.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 5/31/2022 via BusinessWire

Astorg, will acquire Open Health

synopsis: Astorg and Amulet Capital Partners have signed a binding agreement whereby Astorg will acquire OPEN Health, a leading global provider of scientific communications and market access services to the pharmaceutical industry.
buyer: Astorg
Astorg is a leading independent private equity firm with over €17 billion of assets under management. Astorg works with entrepreneurs and management teams to acquire market leading global companies and provide them with strategic guidance, governance, and capital. "
target parent: Amulet Capital Partners LP
target: Open Health
OPEN Health is one of the leading global providers of scientific communications and market access services helping pharmaceutical companies to unlock the full potential of their clinical and commercial assets.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/18/2020 via BNC Analysis

AIM Communication Srl, acquired GAS Communication & Partners s.r.l.

synopsis: AIM Communication, part of AIM Group, has acquired the majority stake in Gas Communication, a PR and media relations agency specialising in the health sector. Gas Communication has been offering communication consultancy and highly professional services since 1999.
buyer parent: AIM Group International S.P.A.
buyer: AIM Communication Srl
AIM Communication, part of AIM Group, is the open innovation network dedicated to communication, brand activation and digital technologies. Its network includes agencies Vangogh, Nautes and the Fandango Club. "
target: GAS Communication & Partners s.r.l.
Based in Italy, GAS Communication is a communication and public relations agency specialized in the health sector, which has been offering communication consultancy and highly professional services since 1999.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/23/2020 via PR Newswire

Ruder Finn, Inc., acquired jacobstahl

synopsis: Global independent PR agency Ruder Finn announced that it has acquired jacobstahl, a full-service public relations agency specializing in healthcare (Rx and OTC), health and well being, consumer and corporate communications. jacobstahl was founded in 2003.
buyer: Ruder Finn, Inc.
Ruder Finn is one of the largest independent global communications and creative agencies with headquarters in the US and China. It is organized around four strategic pillars that reflect its key areas of leadership: Health & Wellness, Corporate & Public Trust, Global Connectivity, and Life & Style. "
target: jacobstahl
jacobstahl is a full-service agency specializing in healthcare (Rx and OTC), health and well being, consumer and corporate communications. jacobstahl was founded in 2003.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/21/2020 via BNC Analysis

Waterland Private Equity Investments, acquired Integrated Medhealth Communication

synopsis: Dutch firm Waterland Private Equity has bought a significant majority stake in UK-based consultancy Integrated Medhealth Communication (IMC). IMC provides healthcare communication and medical affairs support to over 50 pharmaceutical, biotech, vaccine, device, and diagnostic companies globally.
buyer: Waterland Private Equity Investments
Based in the Netherlands, Waterland is an independent private equity investment group that supports entrepreneurs in realising their growth ambitions. Waterland enables its portfolio companies to achieve accelerated growth both organically and through acquisitions. "
target: Integrated Medhealth Communication
Founded in 2006, Integrated Medhealth Communication (IMC) provides healthcare communication and medical affairs support to over 50 pharmaceutical, biotech, vaccine, device, and diagnostic companies globally, including eight of the 20 largest drug companies in the world.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/1/2019 via BusinessWire

M Booth, purchased US Division from Health Unlimited

synopsis: Next15 has acquired US division of Health Unlimited, a leading global health consultancy and communications agency advancing landmark developments in some of the most complex and challenging areas in health. Health Unlimited will be rebranded as M Booth Health and operate as a separate agency reporting to M Booth CEO Dale Bornstein.
buyer parent: Next 15
buyer: M Booth
M Booth is an agency that is known for award-winning integrated marketing programs that engage stakeholders through digital, social, earned media, and experiential channels. M Booth is a wholly owned subsidiary of the Next Fifteen Communications Group. "
seller parent: Dbay Advisors
seller: Health Unlimited
Health Unlimited US Division, rebranded M Booth Health, is a 25-year-old NY-based global health consultancy and communications agency built by specialists with a legacy of advancing landmark developments in global health and medicine.
price ($mm)
$28
rev ($mm)
$17
EBITDA ($mm)
EV / rev
2.6x
EV / EBITDA
closed 12/4/2018 via BusinessWire

Open Health merged with Peloton Advantage,

synopsis: Amulet Capital Partners, a middle-market private equity investment firm based in Greenwich, CT, focused exclusively on the healthcare sector, announced that it has acquired OPEN Health, a multi-disciplinary health communications and market access group. Amulet plans to merge OPEN Health with its existing portfolio company, Peloton Advantage.
buyer parent: Amulet Capital Partners LP
buyer: Peloton Advantage
Peloton Advantage, LLC is a medical communications company specializing in strategic publication planning and associated content development for medical education programs. "
target parent: Providence Equity Partners Inc.
target: Open Health
OPEN Health is a multi-disciplinary health communications and market access group, operating within four core business areas: Medical Communications; Patient and Brand Communications; Value, Informatics and Evidence; Consulting and Commercialization.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/19/2018 via BNC Analysis

Cello Health Communications, purchased Healthcare Team from Firstlight Public Relations

synopsis: Cello Health Communications has acquired the ten-strong healthcare team at Firstlight Public Relations. Firstlight’s healthcare team, which was established in 2011 by Pat Pearson, will now be called Cello Health Public Relations and is located in central London. Firstlight's healthcare team provides healthcare public relations services.
buyer parent: Cello Health plc
buyer: Cello Health Communications
Cello Health Communications provides the full range of evidence through engagement solutions to biopharma, device, diagnostic and consumer companies through the synergistic blend of their strategic, scientific and creative expertise. "
seller: Firstlight Public Relations
Firstlight’s healthcare team, which was established in 2011 by Pat Pearson, provides healthcare public relations services. Firstlight Public Relations is a UK-based full service public relations agency with extensive experience in corporate, B2B, and healthcare communications.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/24/2015 via PR Newswire

Havas Health, acquired Just:: Health Communications

synopsis: Havas Health announced the acquisition of Just:: Health Communications, a leading London agency known for its innovative work and for providing services to global clients in public relations, medical communications, public affairs and digital communications.
buyer parent: Bolloré
buyer: Havas Health
The Havas Health network has a uniquely unified model offering strategy, promotion, medical education, market access, PR and digital solutions inside each agency asset. "
target: Just:: Health Communications
Just:: is a healthcare agency that is committed to working with ambitious, people who share its desire to ask questions, break new ground and make a positive impact. Just:: prides itself on giving confident, honest advice and creating powerful campaigns that resonate with clients and stakeholders.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/3/2015 via GlobeNewswire

A.D.A.M., Inc., acquired Via Media Health

synopsis: Ebix, Inc., a leading supplier of On-Demand software and E-commerce services to the insurance, financial and healthcare industries, announced that it has acquired Via Media Health, one of India's leading health content & communication companies. Via Media Health will be immediately integrated into its A.D.A.M. Health Information Exchange Division.
buyer parent: Ebix, Inc.
buyer: A.D.A.M., Inc. (ADAM:$0.00)
Founded in 1990, A.D.A.M., Animated Dissection of Anatomy for Medicine, has been a worldwide leading provider of consumer health information and benefits technology solutions to health care organizations, hospitals, benefits brokers, employers, consumers, and educational institutions. "
target: Via Media Health
Via Media Health is a 13 years old communication, consulting, and networking organization focused on innovative health communication solutions in India.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/24/2021 via PR Newswire

Open Health, acquired Ark Agency

synopsis: UK-based OPEN Health has acquired ARK, a British data-driven, digital-first creative agency operating in the healthcare sector. Integrating the ARK business with the OPEN Health Group further strengthens OPEN Health's global creative, digital-first resources, and its ability to offer its global clients measurable omnichannel campaigns.
buyer parent: Amulet Capital Partners LP
buyer: Open Health
Based in the UK, OPEN Health brings together deep scientific knowledge, global understanding, and broad specialist expertise to support its clients in improving health outcomes and patient wellbeing. "
target: Ark Agency
UK-based ARK is the first data-driven, digital-first creative agency in healthcare. ARK takes the traditional creative approach to advertising, medical communications and PR and adds data to help sharpen its effectiveness.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/12/2018 via BusinessWire

ICR, acquired Continuum Health Communications

synopsis: ICR, a leading strategic communications and advisory firm serving more than 500 private and public company clients, has acquired Continuum Health Communications, an integrated communications agency specializing in strategy and corporate and product communications.
buyer: ICR
ICR partners with companies to optimize transactions and execute strategic communications programs that achieve business goals, build credibility and enhance long-term enterprise value. ICR is one of the largest and most experienced independent communications and advisory firms in North America. "
target: Continuum Health Communications
Continuum Health Communications is an integrated communications agency specializing in strategy and corporate and product communications. They work across the industry from pharma and biotech, to device and diagnostics, to B2B technology.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/17/2021 via PR Newswire

Fingerpaint Marketing, acquired SPLICE Agency LLC

synopsis: Fingerpaint, a full-service health and wellness marketing firm, has acquired Splice, a company that provides healthcare communication services, including consulting, customer relationship management, branding, content strategy, marketing, biotechnology, pharmaceutical, and medical device advisory services.
buyer: Fingerpaint Marketing
Fingerpaint is a full-service health and wellness marketing firm. They are known for their innovative and data-driven approach to providing analytics-enabled, integrated marketing solutions to healthcare clients, specifically in the pharmaceutical, rare disease, and gene therapy sectors. "
target: SPLICE Agency LLC
SPLICE Agency provides healthcare communication services, including consulting, customer relationship management, branding, content strategy, marketing, biotechnology, pharmaceutical, and medical device advisory services. The company was incorporated in 2014 and is based in Emeryville, California.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/27/2020 via BNC Analysis

Prime Global Medical Communications Ltd., acquired Cambridge Medical Communication

synopsis: Prime Global has bought Cambridge Medical Communication in a deal that will see the UK-based company join its stable of six agencies and two consultancies. Cambridge Medical Communication is an independent medical communications agency based near Cambridge, UK.
buyer: Prime Global Medical Communications Ltd.
Prime Global is a group of seven full-service Medical Communications agencies and two specialist consultancies. They provide the world’s leading biotech, pharma and healthcare businesses with professional communications and strategic consultancy services. "
target: Cambridge Medical Communication
Cambridge Medical Communication is an independent medical communications agency based near Cambridge, UK. Founded in 1998 by Managing Director, Jenny Muiry PhD, Cambridge Medical Communication has built up a formidable reputation for providing clear and imaginative medical communication materials.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/28/2022 via Yahoo, Inc.

Dentsu Health, acquired ANTIBODY Healthcare Communications

synopsis: Dentsu announced the merger of Antibody, Canada’s premier full-service communications agency, with Dentsu Health. The merger follows on the heels of rapid growth for the global healthcare solution. Antibody was formed with the goal to re-invent the healthcare communications agency and build the first agency that is a true strategic partner.
buyer parent: Dentsu Inc.
buyer: Dentsu Health
Dentsu health is an integrated solution that is transforming the healthcare agency services model through a global teaming platform of 2,000+ experts, specializing in health, wellness and pharmaceutical marketing. "
target: ANTIBODY Healthcare Communications
Antibody is Canada’s premier full-service communications agency. Antibody was formed with the goal to re-invent the healthcare communications agency and build the first agency that is a true strategic partner.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/2/2012 via GlobeNewswire

Paul Werth Associates, acquired Generations Sync

synopsis: Paul Werth Associates, an integrated communications firm based in Columbus, Ohio, has acquired Generations Sync, a Chicago-based boutique firm specializing in health care public relations and direct marketing. Generations Sync is immediately changing its name to Paul Werth Associates.
buyer: Paul Werth Associates
Paul Werth Associates is an independent, full-service communications firm that helps grow businesses, launch brands and shape strategies for some of the Midwest's leading organizations. Its competencies include public relations, public affairs, marketing and branding, B2B advertising, and research. "
target: Generations Sync
Generations Sync is a boutique firm specializing in health care public relations and direct marketing. It produces stronger brands and loyal customers by integrating emerging technologies with traditional disciplines such as strategy, promotional education, and direct marketing.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/6/2019 via BusinessWire

W2O Group, acquired ISO.health

synopsis: W2O, the leading independent provider of analytics-driven, digital-first marketing communications to the healthcare sector, announced the acquisition of ISO.health, a London-based medical communications agency.
buyer: W2O Group
W2O is an independent provider of analytics-driven, digital-first marketing and communications to the healthcare sector. W2O applies analytics models, methodologies and approaches in a digital world to design precise communications and marketing strategies to deliver sustained business results. "
target: ISO.health
ISO.health is a London-based medical communications agency. ISO comprises a talented team of industry experts who are adept at developing and delivering impactful omni-channel medical and scientific educational programs for pharmaceutical, biotech and life sciences companies and organizations.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/11/2022 via BNC Analysis

Spectrum Science Communications, Inc., acquired Aurora Healthcare Communications Limited

synopsis: Spectrum Science, an independent, integrated marketing, communications and media agency hyper-focused on health and science, acquired UK-based strategic communications consultancy, Aurora Healthcare Communications. Aurora is a strategic communications consultancy helping the world’s leading healthcare organizations improve lives and prove it.
buyer: Spectrum Science Communications, Inc.
Spectrum Science is an integrated marketing, communications and media agency hyper-focused on health and science. Spectrum leverages human-centered insights, motivating creative, innovative storytelling and technology to reach audiences where they are with the content they need and want. "
target: Aurora Healthcare Communications Limited
Aurora is a strategic communications consultancy helping the world’s leading healthcare organizations improve lives and prove it. Since 2005, Aurora has run campaigns that reach, inspire and activate audiences including patients, families and caregivers, healthcare professionals and beyond.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/10/2018 via BusinessWire

Fishawack Group, acquired Blue Latitude Health

synopsis: The Fishawack Group of Companies, one of the world’s largest independent medical communications and medical marketing organizations, has acquired Blue Latitude Health, a creative consultancy combining the commercial focus of a consultancy with the creative vision of an agency. BLH focuses on the commercialization of healthcare innovations.
buyer: Fishawack Group
Based in the UK, the Fishawack Group of Companies is one of the largest independent medical communications specialists with offices in the UK, USA, Switzerland, and India. For over 17 years, they have been partnering with global and regional pharmaceutical, biotechnology, and medical device clients."
target: Blue Latitude Health
Blue Latitude Health is a creative consultancy combining the commercial focus of a consultancy with the creative vision of an agency. Focused on the commercialization of healthcare innovations, they operate globally and regionally at a brand, portfolio and organizational level.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/9/2020 via BNC Analysis

Envision Pharma Group, acquired 90Ten

synopsis: Global healthcare communications consultancy 90TEN has been acquired by Envision Pharma Group, a global provider of evidence-based communication services and industry-leading technology solutions. The acquisition of 90TEN extends Envision’s footprint in patient engagement and medical communications with its behavioral science methodology.
buyer parent: Ardian
buyer: Envision Pharma Group
Envision Pharma Group is a global technology and scientific communications company serving pharmaceutical, biotechnology, and medical device companies. Envision is a leading provider of evidence-based communication services and industry-leading technology solutions through its iEnvision platform. "
target: 90Ten
90TEN is a global healthcare communications consultancy that aims to make people healthier and happier through education and communications. The company provides PR, medical communications, and patient advocacy services that use behavioral science methodologies to maximize brand and health outcomes.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/24/2021 via BNC Analysis

Envision Pharma Group, acquired doDOC Corp.

synopsis: Envision Pharma Group, a leading global technology-enabled scientific communications company, is pleased to announce the acquisition of doDOC Corp., a leader in document collaborative review, editing, and authoring. doDoc was founded by MIT alumni in 2015 in Boston, MA, and with a European base in Coimbra, Portugal.
buyer parent: GHO Capital
buyer: Envision Pharma Group
Envision Pharma Group is a global technology and scientific communications company serving pharmaceutical, biotechnology, and medical device companies. Envision is a leading provider of evidence-based communication services and industry-leading technology solutions through its iEnvision platform. "
target: doDOC Corp.
Founded by MIT alumni in 2015 in Boston, MA, and with a European base in Coimbra, Portugal, doDOC has the mission to transform the way life sciences teams write and review their documents, offering cloud-based software for enterprise documentation.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/11/2020 via BNC Analysis

A Consortium of 4 Buyers acquired Envision Pharma Group

synopsis: GHO Capital, together with Mubadala Investment Company, the Abu Dhabi-based sovereign investor, and including HarbourVest Partners and Northwestern Mutual, acquired the majority stake in Envision from Ardian SAS, a Paris-based global buyout firm. Envision Pharma Group is a global technology and scientific communications.
buyer: Mubadala Investment Company
buyer: HarbourVest Partners, LLC
buyer: GHO Capital
buyer: Northwestern Mutual
GHO Capital Partners LLP, is a leading specialist healthcare investment advisor based in London. Mubadala is a pioneering global investor. HarbourVest is an independent, global private markets asset manager. Northwestern Mutual helps families and businesses achieve financial security. "
target parent: Ardian
target: Envision Pharma Group
Envision Pharma Group is a global technology and scientific communications company serving pharmaceutical, biotechnology, and medical device companies. Envision is a leading provider of evidence-based communication services and industry-leading technology solutions through its iEnvision platform.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/9/2020 via BNC Analysis

Envision Pharma Group, acquired 90Ten

synopsis: Global healthcare communications consultancy 90TEN has been acquired by Envision Pharma Group, a global provider of evidence-based communication services and industry-leading technology solutions. The acquisition of 90TEN extends Envision’s footprint in patient engagement and medical communications with its behavioral science methodology.
buyer parent: Ardian
buyer: Envision Pharma Group
Envision Pharma Group is a global technology and scientific communications company serving pharmaceutical, biotechnology, and medical device companies. Envision is a leading provider of evidence-based communication services and industry-leading technology solutions through its iEnvision platform. "
target: 90Ten
90TEN is a global healthcare communications consultancy that aims to make people healthier and happier through education and communications. The company provides PR, medical communications, and patient advocacy services that use behavioral science methodologies to maximize brand and health outcomes.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/13/2016 via PE Hub

Ardian, GHO Capital, acquired Envision Pharma, Inc.

synopsis: Leading middle-market private equity firm, The Halifax Group, announced that it has sold Envision Pharma Group to Ardian and GHO Capital. Envision is a recognized strategic partner for Medical Affairs teams within biopharma, providing scientific data communication services and industry-leading technology solutions.
buyer: Ardian
buyer: GHO Capital
Ardian is an independent private investment company with assets of US$55bn managed or advised in Europe, North America and Asia. Global Healthcare Opportunities, or GHO Capital, was founded in 2014 as a specialist healthcare investment adviser based in London. "
target parent: Halifax Group
target: Envision Pharma, Inc.
Envision is a recognized strategic partner for Medical Affairs teams within biopharma, providing scientific data communication services and industry-leading technology solutions.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/19/2013 via BusinessWire

Halifax Group, acquired Envision Pharma, Inc.

synopsis: The Halifax Group, a leading middle-market private equity firm, announced that it has acquired Envision Pharma, Inc. from a subsidiary of Express Scripts Holding Co. Envision is an innovative global technology and scientific communication company focused on the pharmaceutical, biotechnology and medical device industries.
buyer: Halifax Group
The Halifax Group is a private equity firm that invests between $10 and $40 million alongside owners and managers of established, growing and profitable companies that are leaders in their market niche. "
target parent: Express Scripts Inc.
target: Envision Pharma, Inc.
Envision Pharma, founded in 2001, is an innovative global technology and scientific communication company serving pharmaceutical, biotechnology and medical device companies.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/15/2008 via PR Newswire

United BioSource Corporation, acquired Envision Pharma, Inc.

synopsis: United BioSource Corporation acquired Envision Pharma, a leading scientific communications and technology company. With a focus on the pharmaceutical and biotechnology industry, Envision integrates scientific communication services and targeted software applications.
buyer parent: Oak Investment Partners
buyer: United BioSource Corporation
United BioSource Corporation accelerates the generation, analysis and communication of real world evidence by integrating scientific and operational expertise with innovative technology solutions to support global development and commercialization of medical products for life science companies. "
target: Envision Pharma, Inc.
Envision Pharma is an innovative scientific communications and technology company providing commercially focused, strategically driven scientific and technology solutions to the pharmaceutical, biotechnology and device industries.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/11/2020 via BNC Analysis

A Consortium of 4 Buyers acquired Envision Pharma Group

synopsis: GHO Capital, together with Mubadala Investment Company, the Abu Dhabi-based sovereign investor, and including HarbourVest Partners and Northwestern Mutual, acquired the majority stake in Envision from Ardian SAS, a Paris-based global buyout firm. Envision Pharma Group is a global technology and scientific communications.
buyer: Mubadala Investment Company
buyer: HarbourVest Partners, LLC
buyer: GHO Capital
buyer: Northwestern Mutual
GHO Capital Partners LLP, is a leading specialist healthcare investment advisor based in London. Mubadala is a pioneering global investor. HarbourVest is an independent, global private markets asset manager. Northwestern Mutual helps families and businesses achieve financial security. "
target parent: Ardian
target: Envision Pharma Group
Envision Pharma Group is a global technology and scientific communications company serving pharmaceutical, biotechnology, and medical device companies. Envision is a leading provider of evidence-based communication services and industry-leading technology solutions through its iEnvision platform.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/13/2016 via PE Hub

Ardian, GHO Capital, acquired Envision Pharma, Inc.

synopsis: Leading middle-market private equity firm, The Halifax Group, announced that it has sold Envision Pharma Group to Ardian and GHO Capital. Envision is a recognized strategic partner for Medical Affairs teams within biopharma, providing scientific data communication services and industry-leading technology solutions.
buyer: Ardian
buyer: GHO Capital
Ardian is an independent private investment company with assets of US$55bn managed or advised in Europe, North America and Asia. Global Healthcare Opportunities, or GHO Capital, was founded in 2014 as a specialist healthcare investment adviser based in London. "
target parent: Halifax Group
target: Envision Pharma, Inc.
Envision is a recognized strategic partner for Medical Affairs teams within biopharma, providing scientific data communication services and industry-leading technology solutions.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/19/2013 via BusinessWire

Halifax Group, acquired Envision Pharma, Inc.

synopsis: The Halifax Group, a leading middle-market private equity firm, announced that it has acquired Envision Pharma, Inc. from a subsidiary of Express Scripts Holding Co. Envision is an innovative global technology and scientific communication company focused on the pharmaceutical, biotechnology and medical device industries.
buyer: Halifax Group
The Halifax Group is a private equity firm that invests between $10 and $40 million alongside owners and managers of established, growing and profitable companies that are leaders in their market niche. "
target parent: Express Scripts Inc.
target: Envision Pharma, Inc.
Envision Pharma, founded in 2001, is an innovative global technology and scientific communication company serving pharmaceutical, biotechnology and medical device companies.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/15/2008 via PR Newswire

United BioSource Corporation, acquired Envision Pharma, Inc.

synopsis: United BioSource Corporation acquired Envision Pharma, a leading scientific communications and technology company. With a focus on the pharmaceutical and biotechnology industry, Envision integrates scientific communication services and targeted software applications.
buyer parent: Oak Investment Partners
buyer: United BioSource Corporation
United BioSource Corporation accelerates the generation, analysis and communication of real world evidence by integrating scientific and operational expertise with innovative technology solutions to support global development and commercialization of medical products for life science companies. "
target: Envision Pharma, Inc.
Envision Pharma is an innovative scientific communications and technology company providing commercially focused, strategically driven scientific and technology solutions to the pharmaceutical, biotechnology and device industries.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 5/30/2019 via BusinessWire

Evidera, will acquire Medimix International

synopsis: Evidera, a business unit of PPD, LLC, and a provider of evidence-based solutions demonstrating the real-world effectiveness and safety of health care products, will acquire Medimix International, a global technology company providing real-world evidence (RWE) insights and information to the pharmaceutical, diagnostic and medical device industries.
buyer parent: Carlyle Group
buyer: Evidera
Evidera, a PPD business unit, is a leading provider of evidence-based solutions to demonstrate the real-world effectiveness, safety and value of health care products. They help biopharmaceutical, biotechnology and medical device companies generate the evidence needed to optimize the market access. "
target: Medimix International
Medimix International specializes in providing business understanding, real-world evidence insights to the pharmaceutical and medical device industries. Medimix’s primary solution, LiveTracker™, is a cloud-based platform that provides real-time monitoring of clients’ particular therapeutic markets.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/15/2021 via BusinessWire

Scientist.com, acquired InsideScientific Corporation

synopsis: Scientist.com, the life science industry’s leading R&D marketplace, announced that it has completed the acquisition of InsideScientific, an online educational platform for life science researchers. InsideScientific is an online environment rich with information for life science researchers.
buyer: Scientist.com
Scientist.com is the pharmaceutical industry’s leading AI-powered marketplace for outsourced R&D. The marketplace simplifies R&D sourcing, saves time and money, reduces risk, and provides access to the latest innovative tools and technologies. "
target: InsideScientific Corporation
InsideScientific is an online educational platform for life science researchers. InsideScientific is an online environment rich with information for life science researchers. Resources include educational webinars, in-lab workshops and training programs, laboratory protocols, and more.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/17/2009 via PR Newswire

Pharmaceutical Institute, acquired GeneEd, Inc.

synopsis: Pharmaceutical Institute announced that it has acquired e-learning assets from GeneEd, Inc., a company specializing in life science courseware. These assets, including 155 highly advanced e-courses, help expand Pharmaceutical Institute's already extensive library of training resources.
buyer parent: Campbell Alliance Group, Inc.
buyer: Pharmaceutical Institute
Pharmaceutical Institute is a leading provider of specialized training programs for the pharmaceutical and biotech industry. They partner with subject matter experts from Campbell Alliance, the parent company, to develop highly impactful dstance learning solutions for pharma professionals. "
target: GeneEd, Inc.
GeneEd is a provider of life science e-learning content.Two scientists and a retired venture capitalist founded GeneEd in 1997. Dr. Sunil Maulik and Dr. Salil Patel have more than 15 years of industry and teaching experience at Roche Bioscience, Doubletwist and other life science companies.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 1/30/2020 via BNC Analysis

ResMed, will acquire Snapworx, LLC

synopsis: ResMed announced that it agreed to acquire SnapWorx, a privately held software company providing patient contact management and workflow optimization for the sleep apnea resupply market. SnapWorx's software platform automates workflow and document retrieval.
buyer: ResMed (RMD:$3,443.76)
ResMed, a world-leading connected health company with cloud-connected devices for daily remote patient monitoring, changes lives with every breath. Its devices and software solutions help treat and manage sleep apnea, chronic obstructive pulmonary disease and other respiratory conditions. "
target: Snapworx, LLC
SnapWorx, a privately held software company providing patient contact management and workflow optimization for the sleep apnea resupply market. SnapWorx’s software platform automates workflow and document retrieval.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/4/2021 via BNC Analysis

Vespa Capital, acquired SelectScience

synopsis: Vespa Capital, a UK private equity investor, has acquired SelectScience Limited. Bath based SelectScience was founded by Arif and Louise Butt over 20 years ago and has become one of the world’s leading, independent digital publishers providing reputable science technology and research news and trusted product reviews.
buyer: Vespa Capital
Vespa Capital is an established Private Equity investor in the UK lower mid-market. With over £200m of funds under management, they focus on Management Buy Outs and recapitalisations of privately owned businesses with an Enterprise Value between £10m and £70m. "
target: SelectScience
Bath-based SelectScience was founded by Arif and Louise Butt over 20 years ago and has become one of the world’s leading, independent digital publishers providing reputable science technology and research news and trusted product reviews.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/29/2011 via Market Wire

CompareNetworks, Inc., acquired Russell Publishing LLC

synopsis: CompareNetworks, Inc. announced the acquisition of Russell Publishing LLC, complementing the company's innovative online marketplaces with industry-leading pharmaceutical publications. Russell Publishing's titles include American Pharmaceutical Review, Pharmaceutical Outsourcing and International Drug Discovery.
buyer parent: Alta Communications
buyer: CompareNetworks, Inc.
CompareNetworks operates targeted, online, B2B marketplaces for professionals worldwide. The company integrates online marketplaces, email newsletters, award-winning video, whitepapers and editorial content to bring buyers and sellers together. "
target: Russell Publishing LLC
Russell Publishing LLC, a privately held company founded in 1998 and based in Indianapolis, IN, is one of the leading publishers of life science B2B publications in the world. The company's three titles and websites cover all aspects of the pharmaceutical and biopharmaceutical pipeline.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/3/2010 via BusinessWire

Canon Communications, LLC, acquired Pharmalot

synopsis: Canon Communications LLC, announced that it has acquired Pharmalot. As part of the acquisition, Pharmalot’s founder, Ed Silverman, will join Canon as an Editor at Large in the Pharmaceutical Media Group and will continue as Pharmalot’s Editor.
buyer parent: Spectrum Equity Investors
buyer: Canon Communications, LLC
Canon Communications LLC produces tradeshows and conferences for both U.S. and international markets. Canon also publishes magazines and digital media for medical devices, microelectronics, plastics processing, packaging, and other advanced design and manufacturing markets. "
target: Pharmalot
Pharmalot is an influential blog focused on news and information in the pharmaceutical industry. Pharmalot is written by Ed Silverman, a prize-winning journalist who has covered the pharmaceutical industry for the past 15 years.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/17/2022 via PR Web

Red Nucleus Solutions LLC, acquired Yukon Training

synopsis: Red Nucleus, a premier provider of strategic learning and development, scientific services and advisory, and medical communications solutions exclusively for the life sciences industry, has acquired Yukon Training, a leading provider of online modules, off-the-shelf content, and workshops focused on the biopharma and medical device industries.
buyer parent: The Riverside Company
buyer: Red Nucleus Solutions LLC
Red Nucleus is the premier provider of strategic learning and development, scientific services and advisory, and medical communications solutions exclusively for the life sciences industry. "
target: Yukon Training
Yukon Training is a leading provider of online modules, off-the-shelf content, and workshops focused on the biopharma and medical device industries. Yukon customizes its courses to meet each company’s objectives including live, virtual or licensing options for its blended learning workshops.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/24/2014 via Market Wire

Bio-IT World, acquired OpenHelix, LLC

synopsis: OpenHelix, a provider of online and onsite training on some of the most popular and powerful open-access bioinformatics resources on the web, will join the Cambridge Healthtech Institute as a division of Bio-IT World, a leading source of news and opinion on technology and strategic innovation in the life sciences.
buyer parent: Cambridge Healthtech Institute
buyer: Bio-IT World
Bio-IT World, Inc., publishes information across a variety of media to meet the needs of bio-IT, life sciences, healthcare, pharmaceutical and regulatory professionals. "
target: OpenHelix, LLC
OpenHelix, a Washington State company, was founded in 2003 to provide training on what was then a fledgling but quickly growing market of open access web based bioinformatics resources.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/3/2013 via Company Press Release

Thomson Reuters, acquired BioWorld

synopsis: BioWorld and its companion publication Medical Device Daily (MDD) have been acquired by Thomson Reuters, the world’s leading source of intelligent information for businesses and professionals. BioWorld covers news on public companies and hard-to-find information on private companies.
buyer: Thomson Reuters (TRI:$6,348.00)
Thomson Reuters is the world's leading source of intelligent information for businesses and professionals. It combines industry expertise with innovative technology to deliver critical information to leading decision makers. "
target parent: Thompson Media Group LLC
target: BioWorld
BioWorld covers news on public companies and hard-to-find information on private companies. This news coverage of the biotechnology industry is 100 percent original and available only at BioWorld.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/2/2006 via Company Press Release

Cambridge Heathtech Institute, acquired Bio-IT World

synopsis: Cambridge Healthtech Institute of Newton today announced the acquisition of Bio-IT World, Inc.’s media and events properties. The flagship publication, Bio-IT World magazine, introduced in March 2002, has grown from a 10-times-per-year publication to include a range of online and event businesses.
buyer: Cambridge Heathtech Institute
Cambridge Healthtech Institute’s renowned conferences are the underpinning for all our other information resources. Each year, CHI organizes over 80 conferences held throughout the US. including The Molecular Medicine Tri-Conference, Beyond Genome, PepTalk and the World Pharmaceutical Congress. "
target parent: International Data Group
target: Bio-IT World
Bio-IT World, Inc., publishes information across a variety of media to meet the needs of bio-IT, life sciences, healthcare, pharmaceutical and regulatory professionals.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/2/2022 via BNC Analysis

M3.com, acquired MirVracha LCC

synopsis: M3, Japan's largest portal site dedicated to healthcare professionals, has acquired MirVracha, which operates the medical professional website "МирВрача" with over 400,000 medical professional members, equivalent to roughly 60% of all physicians in Russia, and mainly provides marketing support services for pharmaceutical companies.
buyer: M3.com (TSE:2413:$1,724.14)
M3.com is Japan's largest portal site dedicated to healthcare professionals. M3.com provides the latest medical news, overseas journal article summaries, and medical resources. The portal offers information on clinical trials and other services in the healthcare and pharmaceutical industries. "
target: MirVracha LCC
MirVracha operates the medical professional website "МирВрача" with over 400,000 medical professional members, equivalent to roughly 60% of all physicians in Russia, and mainly provides marketing support services for pharmaceutical companies.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/21/2019 via BusinessWire

Xcenda, acquired Dymaxium, Inc.

synopsis: Xcenda, a part of AmerisourceBergen, announced the acquisition of Dymaxium, a trusted market access partner specializing in the exchange of evidence and information between payers and life science companies through its FormularyDecisions.com® platform.
buyer parent: AmerisourceBergen Corporation
buyer: Xcenda
Xcenda, part of AmerisourceBergen, is a strategic consultancy with 20+ years of experience applying real-world expertise in health economics and outcomes research, reimbursement, stakeholder insights, and market access consulting and communications. "
target: Dymaxium, Inc.
Dymaxium is a trusted market access partner specializing in the exchange of evidence and information between payers and life science companies through its FormularyDecisions.com® platform.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/17/2008 via Company Press Release

Decision Resources, Inc., acquired Fingertip Formulary

synopsis: Decision Resources, Inc., one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare industry insight and analysis, announced that it acquired Fingertip Formulary, the leading provider of access to and insight into formulary data in the United States.
buyer parent: Providence Equity Partners Inc.
buyer: Decision Resources, Inc.
Decision Resources, Inc. is a world leader in research publications, advisory services and consulting designed to help clients shape strategy, allocate resources and master their chosen markets. Decision Resources consists of the medical technology business unit and the biopharma business unit. "
target: Fingertip Formulary
Fingertip Formulary offers comprehensive formulary data covering commercial, Medicaid, Medicare, and PBM plans, among others, in the United States. Fingertip Formulary offers a variety of unique data and marketing solutions that provide access to and insight into formulary data.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 11/11/2020 via BNC Analysis

Huntsworth PLC, will acquire Nucleus Global

synopsis: Huntsworth, an international healthcare and communications group, will acquire UK-based Nucleus Global, one of the world’s largest medical specialist communications groups. The addition of Nucleus Global to Huntsworth creates one of the largest high science teams in the world to meet the needs of next-generation prescription drug development.
buyer parent: Clayton, Dubilier & Rice, Inc.
buyer: Huntsworth PLC (LSE:HNT:$342.69)
UK-based Huntsworth is an international healthcare and communications group. The Group's principal areas of focus are marketing, medical, and immersive communications services to healthcare clients, which are primarily large and mid-size pharmaceutical and biotech companies. "
target: Nucleus Global
UK-based Nucleus Global is a medical communications group that provides strategic communications, publications planning, experts and patients engagement, scientific events management, medical education, internal communications, trainings, and more for pharmaceutical and biotechnology companies.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/6/2019 via PR Newswire

Crain Communications, Inc., acquired Genomeweb LLC

synopsis: Crain Communications Inc has acquired GenomeWeb, an online news organization serving the global community of scientists, technology professionals and executives who use and develop the latest advanced tools in molecular biology research and molecular diagnostics. GenomeWeb was launched in 1997 and has a staff of 30 employees located in New York.
buyer: Crain Communications, Inc.
Crain Communications is a privately held media company that produces trusted and relevant news publications, lead generation, research and data products, digital platforms, custom publishing, and events with uncompromising integrity. "
target: Genomeweb LLC
GenomeWeb is an independent online news organization based in New York. Since 1997, GenomeWeb has served the global community of scientists, technology professionals, and executives who use and develop the latest advanced tools in molecular biology research and molecular diagnostics.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA

Like 90Ten


read more

90Ten

Verge Scientific Communications, LLC

Open Health

GAS Communication & Partners s.r.l.

jacobstahl

Integrated Medhealth Communication

Health Unlimited

Open Health

Firstlight Public Relations

Just:: Health Communications

Via Media Health

Ark Agency

Continuum Health Communications

SPLICE Agency LLC

Cambridge Medical Communication

ANTIBODY Healthcare Communications

Generations Sync

ISO.health

Aurora Healthcare Communications Limited

Blue Latitude Health

read more

90Ten

read more

doDOC Corp.

Envision Pharma Group

90Ten

Envision Pharma, Inc.

Envision Pharma, Inc.

Envision Pharma, Inc.

read more

Envision Pharma Group

Envision Pharma, Inc.

Envision Pharma, Inc.

Envision Pharma, Inc.

Medimix International

InsideScientific Corporation

GeneEd, Inc.

Snapworx, LLC

SelectScience

Russell Publishing LLC

Pharmalot

Yukon Training

OpenHelix, LLC

BioWorld

Bio-IT World

MirVracha LCC

Dymaxium, Inc.

Fingertip Formulary

Nucleus Global

Genomeweb LLC

Geography
Matching Companies
Ticker: TSE:2413
 
 
 
 
 
 
 
 
M3.com
M3.com
M3.com is Japan's largest portal site dedicated to healthcare professionals. M3.com provides the latest medical news, overseas journal article summaries, and medical resources. The portal offers information on clinical trials and other services in the healthcare and pharmaceutical industries.
year
2021
rev ($mm)
$1,724.14
EBITDA ($mm)
$657.72
EBIT ($mm)
$604.18
Net Income ($mm)
$581.12
Employees
8249
  • drill down
  • watch
Ticker: SYPT
 
 
 
 
 
 
 
 
Scrypt, Inc.
Scrypt, Inc.
Since 1998, Austin-based Scrypt, Inc. has been creating elegant document productivity tools for healthcare that eliminate manual processes and paper to save time and money. Scrypt has more than 30,000 customers across all 50 states.
year
2009
rev ($mm)
$0.27
EBITDA ($mm)
($0.85)
EBIT ($mm)
($0.91)
Net Income ($mm)
Employees
7
  • drill down
  • watch
Ticker: OM:RTC
 
 
 
 
 
 
 
 
Rethinking Care AB
Rethinking Care AB
Rethinking Care introduces a holistic concept in nursing & health, based on 3 interacting spheres of activity - "Software as a service", "Care as a service" & "Health as a service", based on a high level of competence in nursing & healthcare services as well as IT tools developed for health care.
year
2016
rev ($mm)
EBITDA ($mm)
EBIT ($mm)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker: AIM:MED
 
 
 
 
 
 
 
 
MedaPhor
MedaPhor
MedaPhor is a global provider of advanced ultrasound training simulators for medical professionals. Founded in 2004, they have headquarters in Cardiff, UK and San Diego, USA, and our customers are some of the world's leading medical institutions.
year
2017
rev ($mm)
$5.48
EBITDA ($mm)
($2.09)
EBIT ($mm)
($2.82)
Net Income ($mm)
Employees
31
  • drill down
  • watch
Ticker: TSXV:EYC
 
 
 
 
 
 
 
 
Binovi
Binovi
Binovi is a neuro-vision enhancement platform that is designed for vision optimization and the enhancement of cognitive skills related to human performance. Binovi helps improve the lives of the 1 in 4 individuals who suffer from some form of visual impairment besides acuity loss.
year
2020
rev ($mm)
$0.42
EBITDA ($mm)
($4.63)
EBIT ($mm)
($4.76)
Net Income ($mm)
Employees
0
  • drill down
  • watch
Ticker:
 
 
 
 
 
 
 
 
Clarivate plc
Clarivate plc
Clarivate is a global leader in providing solutions to accelerate the lifecycle of innovation. Clarivate helps customers discover, protect and commercialize their inventions using its trusted subscription and technology-based solutions coupled with deep domain expertise.
year
2021
rev ($mm)
$1,876.89
EBITDA ($mm)
$599.91
EBIT ($mm)
$62.10
Net Income ($mm)
Employees
11224
  • drill down
  • watch
Ticker: CNSX:NARA
 
 
 
 
 
 
 
 
PanGenomic Health Inc.
PanGenomic Health Inc.
PanGenomic is a digital health platform in Canada. PanGenomic provides people with personal control over their mental health treatments. Their Nara solution is a mental health app that curates natural remedies for individuals to manage and improve their mental wellness.
year
2021
rev ($mm)
EBITDA ($mm)
EBIT ($mm)
($0.26)
Net Income ($mm)
Employees
5
  • drill down
  • watch
Ticker: DB:COP
 
 
 
 
 
 
 
 
CompuGroup Medical AG
CompuGroup Medical AG
CompuGroup Medical is a leading global eHealth provider. Their software and communications solutions assist doctors, dentists, hospitals, pharmacists, associations, networks and other service providers with workflow, diagnosis and therapy.
year
2021
rev ($mm)
$1,158.07
EBITDA ($mm)
$194.47
EBIT ($mm)
$120.69
Net Income ($mm)
$74.78
Employees
8079
  • drill down
  • watch
Ticker: TRHC
 
 
 
 
 
 
 
 
Tabula Rasa Healthcare
Tabula Rasa Healthcare
Tabula Rasa HealthCare (TRHC) is a leader in providing patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk.
year
2022
rev ($mm)
$339.59
EBITDA ($mm)
($27.37)
EBIT ($mm)
($76.52)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker: AIM:EMIS
 
 
 
 
 
 
 
 
EMIS Group PLC
EMIS Group PLC
Egton Medical Information Systems Ltd (EMIS) is the UK's market leading primary care software provider with more than 39 million patient records entrusted to its systems. Its aim is to make good quality, timely patient information available any time, any where through interoperable systems.
year
2021
rev ($mm)
$221.66
EBITDA ($mm)
$54.10
EBIT ($mm)
$47.15
Net Income ($mm)
$38.31
Employees
1515
  • drill down
  • watch
Ticker: EVH
 
 
 
 
 
 
 
 
Evolent Health
Evolent Health
Evolent partners with leading health systems to drive value-based care transformation. By providing clinical, analytical and financial capabilities, Evolent helps physicians and health systems achieve superior quality and cost results.
year
2016
rev ($mm)
$212.24
EBITDA ($mm)
($39.30)
EBIT ($mm)
($52.25)
Net Income ($mm)
Employees
946
  • drill down
  • watch
Ticker: MTBC
 
 
 
 
 
 
 
 
Medical Transcription Billing, Corp.
Medical Transcription Billing, Corp.
MTBC (Medical Transcription Billing, Corp) is a healthcare information technology company that provides a fully integrated suite of proprietary web-based solutions, together with related business services, to healthcare providers, revenue cycle management companies and software vendors.
year
2019
rev ($mm)
$65.19
EBITDA ($mm)
$1.78
EBIT ($mm)
($1.62)
Net Income ($mm)
Employees
2400
  • drill down
  • watch
Ticker: TSXV:THNK
 
 
 
 
 
 
 
 
Think Research
Think Research
Think Research is an industry leader in delivering integrated digital healthcare solutions. Its evidence-based healthcare technology solutions support the clinical decision-making process, standardize care, and improve patient outcomes.
year
2021
rev ($mm)
$18.63
EBITDA ($mm)
($21.80)
EBIT ($mm)
($22.10)
Net Income ($mm)
Employees
189
  • drill down
  • watch
Ticker: K:HLYK
 
 
 
 
 
 
 
 
HealthLynked
HealthLynked
HealthLynked provides a solution for both patient members and providers to improve healthcare through the exchange of medical information. The HealthLynked Network is a cloud-based platform that allows members to connect with their healthcare providers and take more control of their healthcare.
year
2020
rev ($mm)
$4.84
EBITDA ($mm)
($2.77)
EBIT ($mm)
($2.87)
Net Income ($mm)
Employees
37
  • drill down
  • watch
Ticker: TSXV:BIO
 
 
 
 
 
 
 
 
AioCare
AioCare
AioCare, formerly known as Biosign Technologies, develops and sells cloud-based healthcare software products that address the needs in clinic management, home care operations, health monitoring and virtual care management. Their cutting edge technology is transforming Healthcare delivery in Germany.
year
2015
rev ($mm)
$0.38
EBITDA ($mm)
($3.04)
EBIT ($mm)
($3.43)
Net Income ($mm)
$1.21
Employees
16
  • drill down
  • watch